Health X Platform Q2 Results 2026: Net loss ₹13 Cr
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹484Cr
- +60.8% YoY
- +8.3% QoQ
- Net profit
- −₹13Cr
- Q2 FY26: −₹15 Cr
- Margin
- −4.6%
- +3.4 pp YoY
- −2.7 pp QoQ
Guidance rank: #1 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Health X Platform Ltd Q2 FY27 key numbers
- Revenue
- Q2 FY27 revenue from operations: Rs 489.1 Cr, up 58.8% year-on-year.
As stated in Health X Platform Ltd's Q2 FY27 investor presentation · published 14 Nov 2026. Reported figures, not investment advice.
Based on Health X Platform Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY27 revenue from operations: Rs 489.1 Cr, up 58.8% year-on-year (Page 24). Quarterly EBITDA: Rs.
From Health X Platform Ltd's Q2 FY27 earnings-call transcript · updated 14 Nov 2026.
How did Health X Platform's revenue grow in the September 2026 quarter?
- Q2 FY27 revenue from operations: Rs 489.1 Cr, up 58.8% year-on-year (Page 24).
- Q1 FY27 revenue from operations: Rs 440.3 Cr, up 11.1% year-on-year (Page 24).
- Q2 FY26 revenue from operations (comparable quarter last year): Rs 307.9 Cr (Page 24).
- Retailer Shakti Q2 FY27 sales: Rs 428.9 Cr (Page 26).
- SastaSundar Q2 FY27 sales: Rs 54.9 Cr (Page 26).
2 more points from Health X Platform Ltd's call on revenue
Create a free account to keep reading this call
What happened to Health X Platform's margins in Q2 FY27?
Quarterly EBITDA: Rs. (14.9) Cr, down from (78.9) Cr in previous quarter FY26, representing an EBITDA…
Locked: what Health X Platform Ltd said on margins
Also locked on this page: capex, fundraising, order book
Free account, 30 seconds. No card needed.
What capex is Health X Platform planning?
See what Health X Platform Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Health X Platform raising money or cutting debt?
The Historical Consolidated Balance Sheet (Page 29) shows borrowings and other financial liabilities over…
Locked: what Health X Platform Ltd said on fundraising
Also locked on this page: margins, capex, order book
Free account, 30 seconds. No card needed.
How big is Health X Platform's order book?
See what Health X Platform Ltd said on order book & pipeline — free account, 30 seconds.
Health X Platform Ltd — Quarterly revenue & net profit
Health X Platform Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| Revenue | 484 | 301 | +60.8% | 447 | +8.3% |
| Operating profit (EBITDA) | -22 | -23 | — | -8 | — |
| Operating margin | -4.6% | -8% | +3.4 pp | -1.9% | -2.7 pp |
| Profit before tax | -15 | -19 | — | 2 | -850% |
| Net profit (PAT) | -13 | -15 | — | 2 | -750% |
| EPS (₹) | -3.47 | -3.99 | — | 0.80 | -533.7% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹484 Cr, net loss ₹13 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Healthcare Services
Continue your research
What Health X Platform's management said in earlier quarters
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Revenue from operations for the half year ended 30th September 2026 is ₹10,660.84 lakhs, compared to the previous year ended 31st March 2026 figure of…
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- 1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Health X Platform Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Health X Platform Ltd Q2 FY27 results?
Q2 FY27 revenue from operations: Rs 489.1 Cr, up 58.8% year-on-year (Page 24). Quarterly EBITDA: Rs.
What is Health X Platform Ltd share price analysis?
Health X Platform Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹869 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Health X Platform Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
